Key Insights

Highlights

Success Rate

89% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

5.0%

1 terminated out of 20 trials

Success Rate

88.9%

+2.4% vs benchmark

Late-Stage Pipeline

10%

2 trials in Phase 3/4

Results Transparency

50%

4 of 8 completed with results

Key Signals

4 with results89% success

Data Visualizations

Phase Distribution

18Total
Not Applicable (11)
P 1 (2)
P 2 (3)
P 3 (1)
P 4 (1)

Trial Status

Completed8
Unknown4
Active Not Recruiting2
Withdrawn2
Not Yet Recruiting2
Recruiting1

Trial Success Rate

88.9%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (20)

Showing 20 of 20 trials
NCT05139888Not ApplicableCompletedPrimary

Light Therapy for Onychomycosis Study

NCT07382427Phase 2Not Yet RecruitingPrimary

A Phase 2 Study to Assess the Effectiveness of Topical Terbinafine in Participants With Mild to Moderate Onychomycosis of the Toenails

NCT07065773Phase 2Active Not RecruitingPrimary

Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe Onychomycosis

NCT06006455Not ApplicableTerminatedPrimary

Effect of the Erchonia® LunulaLaser™ for the Treatment of Toenail Onychomycosis

NCT05674747Phase 1CompletedPrimary

Pilot Study of Swift Microwave Device for Onychomycosis

NCT06485050Not ApplicableActive Not Recruiting

Photodynamic Therapy and Topical Antifungal for Onychomycosis in Patients With Diabetes.

NCT06417983Not Yet RecruitingPrimary

Topical Application of Essential Oils to Treat Onchomycosis

NCT03382717Not ApplicableCompletedPrimary

Efficacy and Safety of a Medical Device for the Treatment of Toenail Onychomycosis

NCT03066336Not ApplicableWithdrawnPrimary

A Study to See if Low Level Laser Light Can Help to Treat Toenail Fungus

NCT05135910Phase 2UnknownPrimary

To Evaluate Hallux Terbinafine Subungual Gel (HSG) in the Treatment of Onychomycosis

NCT05110638Phase 1UnknownPrimary

Safety and Tolerability Study of SKX-16 in Subjects With Moderate to Severe Distal Subungual Onychomycosis

NCT05260450Not ApplicableCompletedPrimary

Laser Treatment of Toenail Onychomycosis With a 1064 nm Nd:YAG-laser

NCT04961684Not ApplicableCompletedPrimary

Clinical Evaluation of Efficacy and Safety of a Medical Device for the Treatment of Toenail Onychomycosis

NCT03216200Not ApplicableCompletedPrimary

Early Feasibility Study to Evaluate the Efficacy of the RenewalNail™ Plasma Treatment System in Patients With Onychomycosis (Fungal Nail)

NCT04084782UnknownPrimary

An Internet Mediated Research Study to Assess the Quality of Life of Consumers With Self-reported Fungal Nail Infection (Onychomycosis) During Treatment With Scholl Fungal Nail.

NCT04042857Not ApplicableRecruitingPrimary

Safety and Efficacy of Next Science Gel on Toenail Fungus

NCT03110029Phase 4CompletedPrimary

Evaluating the Efficacy and Compatibility of Efinaconazole 10% Solution (Jublia) for the Treatment of Toenail Onychomycosis in Patients Wearing Toenail Polish Compared to Those Without Polish

NCT03141840Not ApplicableCompletedPrimary

Clinical Trial of Topical ABL01 Treatment of Onychomycosis

NCT03094468Phase 3WithdrawnPrimary

Study to Evaluate the Efficacy and Safety of P-3058 Nail Solution in the Treatment of Onychomycosis

NCT03098342Not ApplicableUnknownPrimary

Comparison of Efficacy and Safety Between Methylene Blue-mediated Photodynamic Therapy and 5% Amorolfine Nail Lacquer for Toenail Onychomycosis Treatment

Showing all 20 trials

Research Network

Activity Timeline